• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 309/08 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 309/08

Total number of patents in this class: 222

10-year publication summary

19
16
17
25
13
18
14
25
10
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Corsair Pharma, Inc.
36
13
Bristol-myers Squibb Company
4863
10
The General Hospital Corporation
4650
6
The Broad Institute, Inc.
1709
6
Enanta Pharmaceuticals, Inc.
422
6
Global Blood Therapeutics, Inc.
180
6
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
160
6
The University of Queensland
657
6
Massachusetts Institute of Technology
9913
5
Modernatx, Inc.
1206
5
Theravance Biopharma R&D IP, LLC
517
5
Abbvie Inc.
1782
4
Takeda Pharmaceutical Company Limited
2943
4
Cytokinetics, Inc.
268
4
Dongjin Semichem Co., Ltd.
471
4
Xwpharma Ltd.
59
4
Orsobio, Inc.
12
4
BASF SE
20432
3
Fuso Pharmaceutical Industries, Ltd.
127
3
National University Corporation Gunma University
303
3
Other owners 115